細胞分離和分選市場規模、佔有率和成長分析：按產品類型、細胞類型、方法、細胞來源、應用、最終用途和地區分類－2026-2033年產業預測

2024 年細胞分離和分選市場價值為 99.8 億美元，預計到 2025 年將成長至 110.1 億美元，到 2033 年將成長至 241.2 億美元，在預測期（2026-2033 年）內複合年成長率為 10.3%。

細胞分離和分選市場預計將顯著成長，主要受特定細胞類型相關研究和治療方法需求不斷成長的推動。推動這一成長的關鍵因素包括政府投入的增加、積極的研究以及創新工具的湧現。新興市場由於慢性病盛行率的上升以及對先進治療方案的迫切需求，蘊藏著巨大的商機。磁活化細胞分選 (MACS)、螢光活化細胞分選 (FACS) 和微流體等技術被廣泛用於根據細胞的獨特特徵進行區分。技術進步、生命科學研究投入的增加以及對個人化和再生醫學的關注進一步推動了市場發展。此外，自動化和新型分離技術的整合也為市場注入了新的動態。

細胞分離和分選市場的成長要素

細胞分離和分選市場的成長主要受癌症患者數量不斷增加的推動，而癌症患者數量的增加又反過來刺激了對有效治療方案的需求。此外，政府對細胞研究的支持也促進了該領域的創新。隨著醫療專業人員尋求個人化的治療方案，個人化醫療的日益普及也對該市場產生了進一步的影響。同時，技術的不斷進步提高了細胞分離和分選技術的效率和效果，從而增強了研究能力和臨床應用。這些因素共同造就了充滿活力的市場格局，為市場發展和機會的湧現創造了廣闊的空間。

限制細胞分離和分級市場發展的因素

細胞分離純化設備在科學研究和疾病檢測中具有高精度和高效率，但其高昂的成本是該市場發展的主要障礙。細胞分離的成本涵蓋設備、試劑、試劑盒、血清以及各種服務等諸多方面，所有這些都增加了整體的經濟負擔。此外，建立細胞分離流程所需的初始投資可能相當可觀，而後續使用特定試劑的成本又會進一步增加成本。預計這種經濟負擔將阻礙市場成長，因為許多潛在用戶可能會因高昂的總成本而卻步。

細胞分離與細胞分級市場的發展趨勢

在細胞分離市場，一個顯著的趨勢是微流體技術的應用日益廣泛，以提高細胞流動管理的精確度和效率。這些先進的系統能夠實現更有效率的細胞分離過程，使研究人員和臨床醫生能夠更精確地分離特定細胞群，並減少樣本損失。微流體技術的整合不僅簡化了工作流程，還支援高通量分析，從而推動了從診斷到再生醫學等眾多應用領域的創新。隨著對個人化醫療和先進治療方案的需求不斷成長，微流體技術有望在變革細胞分離和調查方法發揮關鍵作用。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球細胞分離與分選市場規模：依產品分類

• 消耗品
  • 試劑和試劑盒
  • 一次性產品
  • 培養基和血清
  • 珠
• 裝置
  • 離心機
  • 細胞分選儀
  • 過濾系統
  • 磁性細胞分離裝置

全球細胞分離與分選市場規模：依細胞類型分類

• 人類細胞
  • 分化細胞
  • 幹細胞
• 動物細胞
  • 脂肪組織
  • 骨髓
  • 臍帶血/胚胎幹細胞
  • 其他來源

全球細胞分離與分選市場規模：依方法分類

• 離心分離
• 表面標誌物
• 過濾法

全球細胞分離與分選市場規模：按應用領域分類

• 生物分子的分離
• 癌症研究
• 幹細胞研究
• 組織再生
• 體外診斷
• 其他用途

全球細胞分離與分選市場規模：依最終用戶分類

• 製藥公司
• 生技公司
• 學術機構
• 醫院和研究機構

全球細胞分離與分選市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• STEMCELL Technologies Inc.
• Bio-Rad Laboratories, Inc.
• GE Healthcare
• Merck KGaA
• Miltenyi Biotec
• Akadeum Life Sciences
• Takara Bio Inc
• Terumo Corporation
• EMD Millipore
• PerkinElmer
• pluriSelect Life Science UG & Co. KG
• ZEISS
• Abcam plc
• VWR International
• Thermo Fisher Scientific
• Promega Corporation
• Cell Signaling Technology
• Lonza Group AG
• Charles River Laboratories
• Invenra, Inc.

結論與建議

Cell Isolation/Cell Separation Market size was valued at USD 9.98 Billion in 2024 and is poised to grow from USD 11.01 Billion in 2025 to USD 24.12 Billion by 2033, growing at a CAGR of 10.3% during the forecast period (2026-2033).

The cell isolation and separation market is poised for substantial growth, driven by rising demand for precise cell type research and therapeutics. Key factors contributing to this expansion include increased government funding, active research initiatives, and the advent of innovative tools. Emerging economies present significant opportunities, spurred by the rising prevalence of chronic diseases and the pressing need for advanced therapeutic solutions. Techniques such as magnetic-activated cell sorting, fluorescence-activated cell sorting, and microfluidic methods are widely utilized to differentiate cells based on distinct characteristics. The market is further supported by advancements in technology, increased investment in life sciences research, and an emphasis on personalized medicine and regenerative therapies. Additionally, the integration of automation and novel isolation techniques is enhancing market dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cell Isolation/Cell Separation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cell Isolation/Cell Separation Market Segments Analysis

Global Cell Isolation/Cell Separation Market is segmented by product, cell type, cell source, technique, application, end user and region. Based on product, the market is segmented into consumables and instruments. Based on cell type, the market is segmented into human cells and animal cells. Based on cell source, the market is segmented into adipose tissue, bone marrow, cord blood/embryonic stem cells and other cell sources. Based on technique, the market is segmented into centrifugation-based cell isolation, surface marker-based cell isolation and filtration-based cell isolation. Based on application, the market is segmented into biomolecule isolation, cancer research, stem cell research, tissue regeneration & regenerative medicine, in vitro diagnostics and other applications. Based on end user, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes and hospitals & diagnostic laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Cell Isolation/Cell Separation Market

The growth of the Cell Isolation/Cell Separation market is significantly fueled by the increasing prevalence of cancer patients, which drives demand for effective treatment solutions. Additionally, governmental support for cell-based research is fostering innovation in this field. This market is further influenced by a heightened focus on personalized medicine, as healthcare providers look for tailored therapeutic approaches. Moreover, continuous technological advancements are improving the efficiency and efficacy of cell isolation and separation techniques, subsequently enhancing research capabilities and clinical applications. Collectively, these factors are contributing to a dynamic landscape for the market, paving the way for substantial development and opportunities.

Restraints in the Cell Isolation/Cell Separation Market

Despite the accuracy and efficiency that cell isolation and separation equipment offers for scientific research and disease detection, their high costs present a significant obstacle within this market. The expenses associated with cell separation encompass a wide range of components, including equipment, reagents, kits, sera, and various services, all of which contribute to the overall financial burden. Additionally, the initial investment required to set up cell separation processes can be quite substantial, alongside the ongoing costs for application-specific reagents. This financial strain is expected to impede the growth of the market, as many potential users may be deterred by the high overall expenditures.

Market Trends of the Cell Isolation/Cell Separation Market

The Cell Isolation/Cell Separation market is witnessing a significant trend towards the increased adoption of microfluidic technologies, which enhance the precision and efficiency of cell flow management. These advanced systems facilitate more effective cell separation processes, enabling researchers and clinicians to isolate specific cell populations with improved accuracy and reduced sample loss. The integration of microfluidics not only streamlines workflows but also supports high-throughput analyses, driving innovation in applications ranging from diagnostics to regenerative medicine. As the demand for personalized medicine and advanced therapeutic solutions grows, microfluidics is poised to play a pivotal role in transforming cell separation methodologies.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Cell Isolation/Cell Separation Market Size by Product & CAGR (2026-2033)

• Market Overview
• Consumables
  • Reagents & Kits
  • Disposables
  • Media & Sera
  • Beads
• Instruments
  • Centrifuges
  • Cell Sorters
  • Filtration Systems
  • Magnetic Cell Separators

Global Cell Isolation/Cell Separation Market Size by Cell Type & CAGR (2026-2033)

• Market Overview
• Human Cells
  • Differentiated Cells
  • Stem Cells
• Animal Cells
  • Adipose Tissue
  • Bone Marrow
  • Cord Blood/Embryonic Stem Cells
  • Other Sources

Global Cell Isolation/Cell Separation Market Size by Technique & CAGR (2026-2033)

• Market Overview
• Centrifugation
• Surface Marker
• Filtration-Based

Global Cell Isolation/Cell Separation Market Size by Application & CAGR (2026-2033)

• Market Overview
• Biomolecule Isolation
• Cancer Research
• Stem Cell Research
• Tissue Regeneration
• In Vitro Diagnostics
• Other Applications

Global Cell Isolation/Cell Separation Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical Companies
• Biotechnology Companies
• Academic Institutes
• Hospitals & Labs

Global Cell Isolation/Cell Separation Market Size & CAGR (2026-2033)

• North America (Product, Cell Type, Technique, Application, End User)
  • US
  • Canada
• Europe (Product, Cell Type, Technique, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Cell Type, Technique, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Cell Type, Technique, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Cell Type, Technique, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• STEMCELL Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akadeum Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EMD Millipore
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• pluriSelect Life Science UG & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZEISS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VWR International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invenra, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations